相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: evidences from the real-world data
Zhengbiao Xue et al.
HEART FAILURE REVIEWS (2020)
Effectiveness and Safety of Off-label Dosing of Non-vitamin K Antagonist Anticoagulant for Atrial Fibrillation in Asian Patients
Kwang-No Lee et al.
SCIENTIFIC REPORTS (2020)
Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study
Diana-Leh-Ching Ng et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2020)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Craig T. January et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation
Yi-Hsin Chan et al.
CHEST (2019)
Outcomes After Use of Standard- and Low-Dose Non-Vitamin K Oral Anticoagulants in Asian Patients With Atrial Fibrillation
Min Soo Cho et al.
STROKE (2019)
Real-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medica Records
Hun-Sung Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2018)
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation
Yi-Cheng Lin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan
Tze-Fan Chao et al.
CIRCULATION (2018)
Higher Risk of Bleeding in Asians Presenting With ST-Segment Elevation Myocardial Infarction: Analysis of the National Inpatient Sample Database
Naoki Misumida et al.
ANGIOLOGY (2018)
Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
Ka-Shing Cheung et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation
Yi-Hsin Chan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Outcomes in a Warfarin-Treated Population With Atrial Fibrillation
Fredrik Bjorck et al.
JAMA CARDIOLOGY (2016)
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry
Sylvia Haas et al.
PLOS ONE (2016)
Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal
Gregory Y. H. Lip et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Active-comparator design and new-user design in observational studies
Kazuki Yoshida et al.
NATURE REVIEWS RHEUMATOLOGY (2015)
Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation Meta-Analysis
Kang-Ling Wang et al.
STROKE (2015)
Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study
Sumeet S. Chugh et al.
CIRCULATION (2014)
Oral anticoagulants for Asian patients with atrial fibrillation
Ian Sabir et al.
NATURE REVIEWS CARDIOLOGY (2014)
Stroke prevention in atrial fibrillation: An Asian perspective
Chern-En Chiang et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Epidemiology of stroke and its subtypes in Chinese vs white populations A systematic review
Chung-Fen Tsai et al.
NEUROLOGY (2013)
Gastrointestinal bleeding with the new oral anticoagulants - defining the issues and the management strategies
Jay Desai et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins
Goodarz Danaei et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Antithrombotic Therapy for Atrial Fibrillation Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
John J. You et al.
CHEST (2012)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans
Stefan Blech et al.
DRUG METABOLISM AND DISPOSITION (2008)
Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?
JHS You et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
分享论文
